Awards Nomination
20+ Million Readerbase
Indexed In
- RefSeek
- Hamdard University
- EBSCO A-Z
- Publons
- Euro Pub
- Google Scholar
- Quality Open Access Market
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Abstract
Prevention of Opioid Induced Nausea and Vomiting During Treatment of Acute Pain with Combination Antiemetic Opioid Medication: An Update and Review
Timothy W. Neal* and John R. Zuniga
Patients treated with opioids for the management of acute pain often experience opioid induced nausea and vomiting (OINV). OINV compromises pain control, leads to sleep disturbances, and increase in health care costs. Currently, there is no approved therapeutic agent to treat acute pain while preventing and reducing OINV. This has led to the production of Hydexor (CL-108), which is a combination agent containing opioid and an antiemetic. The purpose of this review is to revisit the use of CL-108 as a modality in the reduction of OINV, and to provide an update for use.
Published Date: 2021-07-22; Received Date: 2021-07-01